China · Delayed Price · Currency is CNY Theseus Pharmaceuticals Statistics
Total Valuation
SHA:603507 has a market cap or net worth of CNY 4.98 billion. The enterprise value is 7.47 billion.
| Market Cap | 4.98B |
| Enterprise Value | 7.47B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | Jun 19, 2025 |
Share Statistics
SHA:603507 has 181.95 million shares outstanding. The number of shares has increased by 8.21% in one year.
| Current Share Class | 181.95M |
| Shares Outstanding | 181.95M |
| Shares Change (YoY) | +8.21% |
| Shares Change (QoQ) | +33.86% |
| Owned by Insiders (%) | 22.67% |
| Owned by Institutions (%) | 31.37% |
| Float | 131.66M |
Valuation Ratios
The trailing PE ratio is 44.41 and the forward PE ratio is 16.16.
| PE Ratio | 44.41 |
| Forward PE | 16.16 |
| PS Ratio | 1.28 |
| PB Ratio | 1.97 |
| P/TBV Ratio | 2.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 9.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.60, with an EV/FCF ratio of -27.54.
| EV / Earnings | 61.21 |
| EV / Sales | 1.92 |
| EV / EBITDA | 12.60 |
| EV / EBIT | 22.89 |
| EV / FCF | -27.54 |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 1.49.
| Current Ratio | 1.06 |
| Quick Ratio | 0.67 |
| Debt / Equity | 1.49 |
| Debt / EBITDA | 6.35 |
| Debt / FCF | -13.89 |
| Interest Coverage | 2.57 |
Financial Efficiency
Return on equity (ROE) is 4.74% and return on invested capital (ROIC) is 3.56%.
| Return on Equity (ROE) | 4.74% |
| Return on Assets (ROA) | 2.96% |
| Return on Invested Capital (ROIC) | 3.56% |
| Return on Capital Employed (ROCE) | 8.79% |
| Revenue Per Employee | 1.15M |
| Profits Per Employee | 36,157 |
| Employee Count | 3,376 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 2.68 |
Taxes
In the past 12 months, SHA:603507 has paid 35.72 million in taxes.
| Income Tax | 35.72M |
| Effective Tax Rate | 22.92% |
Stock Price Statistics
The stock price has increased by +30.29% in the last 52 weeks. The beta is 0.10, so SHA:603507's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | +30.29% |
| 50-Day Moving Average | 24.84 |
| 200-Day Moving Average | 25.01 |
| Relative Strength Index (RSI) | 71.19 |
| Average Volume (20 Days) | 12,881,178 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603507 had revenue of CNY 3.88 billion and earned 122.07 million in profits. Earnings per share was 0.62.
| Revenue | 3.88B |
| Gross Profit | 691.92M |
| Operating Income | 326.45M |
| Pretax Income | 155.83M |
| Net Income | 122.07M |
| EBITDA | 542.90M |
| EBIT | 326.45M |
| Earnings Per Share (EPS) | 0.62 |
Balance Sheet
The company has 1.32 billion in cash and 3.77 billion in debt, giving a net cash position of -2.45 billion or -13.46 per share.
| Cash & Cash Equivalents | 1.32B |
| Total Debt | 3.77B |
| Net Cash | -2.45B |
| Net Cash Per Share | -13.46 |
| Equity (Book Value) | 2.53B |
| Book Value Per Share | 10.38 |
| Working Capital | 201.48M |
Cash Flow
In the last 12 months, operating cash flow was 539.66 million and capital expenditures -810.98 million, giving a free cash flow of -271.32 million.
| Operating Cash Flow | 539.66M |
| Capital Expenditures | -810.98M |
| Free Cash Flow | -271.32M |
| FCF Per Share | -1.49 |
Margins
Gross margin is 17.81%, with operating and profit margins of 8.40% and 3.14%.
| Gross Margin | 17.81% |
| Operating Margin | 8.40% |
| Pretax Margin | 4.01% |
| Profit Margin | 3.14% |
| EBITDA Margin | 13.98% |
| EBIT Margin | 8.40% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 1.10%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 1.10% |
| Dividend Growth (YoY) | -23.08% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 136.12% |
| Buyback Yield | -8.21% |
| Shareholder Yield | -7.05% |
| Earnings Yield | 2.45% |
| FCF Yield | -5.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 8, 2024. It was a forward split with a ratio of 1.3.
| Last Split Date | Jul 8, 2024 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHA:603507 has an Altman Z-Score of 1.44 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.44 |
| Piotroski F-Score | 4 |